Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 7
1949 5
1950 5
1951 8
1952 11
1953 16
1954 16
1955 16
1956 10
1957 10
1958 11
1959 12
1960 9
1961 19
1962 16
1963 32
1964 41
1965 47
1966 23
1967 30
1968 47
1969 52
1970 40
1971 62
1972 60
1973 59
1974 74
1975 67
1976 91
1977 56
1978 80
1979 98
1980 79
1981 57
1982 76
1983 55
1984 62
1985 70
1986 41
1987 59
1988 55
1989 56
1990 53
1991 41
1992 62
1993 72
1994 62
1995 61
1996 59
1997 82
1998 78
1999 61
2000 62
2001 61
2002 88
2003 62
2004 44
2005 71
2006 76
2007 62
2008 77
2009 81
2010 104
2011 93
2012 85
2013 223
2014 372
2015 417
2016 401
2017 377
2018 368
2019 366
2020 340
Text availability
Article attribute
Article type
Publication date

Search Results

5,865 results
Results by year
Filters applied: . Clear all
Page 1
Diabetes: a dynamic disease.
The Lancet. The Lancet. Lancet. 2017 Jun 3;389(10085):2163. doi: 10.1016/S0140-6736(17)31537-4. Lancet. 2017. PMID: 28589879 No abstract available.
Diabetes and cognitive dysfunction.
McCrimmon RJ, Ryan CM, Frier BM. McCrimmon RJ, et al. Lancet. 2012 Jun 16;379(9833):2291-9. doi: 10.1016/S0140-6736(12)60360-2. Epub 2012 Jun 9. Lancet. 2012. PMID: 22683129 Review.
Cognitive dysfunction in type 1 and type 2 diabetes share many similarities, but important differences do exist. A primary distinguishing feature of type 2 diabetes is that people with this disorder often (but not invariably) do poorly on measures of learning and me …
Cognitive dysfunction in type 1 and type 2 diabetes share many similarities, but important differences do exist. A primary distinguis …
Diabetes and hypertension: the bad companions.
Ferrannini E, Cushman WC. Ferrannini E, et al. Lancet. 2012 Aug 11;380(9841):601-10. doi: 10.1016/S0140-6736(12)60987-8. Lancet. 2012. PMID: 22883509 Review.
High blood pressure is reported in over two-thirds of patients with type 2 diabetes, and its development coincides with the development of hyperglycaemia. ...A blood pressure of lower than 140/85 mm Hg is a reasonable therapeutic goal in patients with type 2 diabetes
High blood pressure is reported in over two-thirds of patients with type 2 diabetes, and its development coincides with the developme …
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.
International Hypoglycaemia Study Group. International Hypoglycaemia Study Group. Lancet Diabetes Endocrinol. 2019 May;7(5):385-396. doi: 10.1016/S2213-8587(18)30315-2. Epub 2019 Mar 27. Lancet Diabetes Endocrinol. 2019. PMID: 30926258 Free article. Review.
Hypoglycaemia has long been recognised as a dangerous side-effect of treatment of diabetes with insulin or insulin secretagogues. With its potential to disrupt cerebral function, hypoglycaemia can have a major effect on peoples' lives. ...The association is probably partly …
Hypoglycaemia has long been recognised as a dangerous side-effect of treatment of diabetes with insulin or insulin secretagogues. Wit …
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Køber L, Petrie MC, McMurray JJV. Kristensen SL, et al. Lancet Diabetes Endocrinol. 2019 Oct;7(10):776-785. doi: 10.1016/S2213-8587(19)30249-9. Epub 2019 Aug 14. Lancet Diabetes Endocrinol. 2019. PMID: 31422062
INTERPRETATION: Treatment with GLP-1 receptor agonists has beneficial effects on cardiovascular, mortality, and kidney outcomes in patients with type 2 diabetes. FUNDING: None....
INTERPRETATION: Treatment with GLP-1 receptor agonists has beneficial effects on cardiovascular, mortality, and kidney outcomes in patients …
Type 2 diabetes across generations: from pathophysiology to prevention and management.
Nolan CJ, Damm P, Prentki M. Nolan CJ, et al. Lancet. 2011 Jul 9;378(9786):169-81. doi: 10.1016/S0140-6736(11)60614-4. Epub 2011 Jun 24. Lancet. 2011. PMID: 21705072 Review.
Type 2 diabetes is now a pandemic and shows no signs of abatement. In this Seminar we review the pathophysiology of this disorder, with particular attention to epidemiology, genetics, epigenetics, and molecular cell biology. Evidence is emerging that a substantial part of …
Type 2 diabetes is now a pandemic and shows no signs of abatement. In this Seminar we review the pathophysiology of this disorder, wi …
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.
Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GF. Palmer SC, et al. Lancet. 2015 May 23;385(9982):2047-56. doi: 10.1016/S0140-6736(14)62459-4. Lancet. 2015. PMID: 26009228 Review.
METHODS: We did a network meta-analysis of randomised trials from around the world comparing blood pressure-lowering agents in adults with diabetic kidney disease. Electronic databases (the Cochrane Collaboration, Medline, and Embase) were searched systematically up to Jan …
METHODS: We did a network meta-analysis of randomised trials from around the world comparing blood pressure-lowering agents in adults with …
Diabetes: mapping the titanic struggle ahead.
The Lancet Diabetes Endocrinology. The Lancet Diabetes Endocrinology. Lancet Diabetes Endocrinol. 2018 Jan;6(1):1. doi: 10.1016/S2213-8587(17)30414-X. Lancet Diabetes Endocrinol. 2018. PMID: 29273158 No abstract available.
Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
Winzeler B, Cesana-Nigro N, Refardt J, Vogt DR, Imber C, Morin B, Popovic M, Steinmetz M, Sailer CO, Szinnai G, Chifu I, Fassnacht M, Christ-Crain M. Winzeler B, et al. Lancet. 2019 Aug 17;394(10198):587-595. doi: 10.1016/S0140-6736(19)31255-3. Epub 2019 Jul 11. Lancet. 2019. PMID: 31303316 Clinical Trial.
FINDINGS: Between May 24, 2013, and Jan 11, 2017, 52 patients were enrolled in the development cohort (12 [23%] with complete diabetes insipidus, nine [17%] with partial diabetes insipidus, and 31 [60%] with primary polydipsia) alongside 20 healthy adu …
FINDINGS: Between May 24, 2013, and Jan 11, 2017, 52 patients were enrolled in the development cohort (12 [23%] with complete diabetes
Care of diabetes in children and adolescents: controversies, changes, and consensus.
Cameron FJ, Wherrett DK. Cameron FJ, et al. Lancet. 2015 May 23;385(9982):2096-106. doi: 10.1016/S0140-6736(15)60971-0. Lancet. 2015. PMID: 26009230 Review.
Although most children with diabetes have type 1 diabetes, the increasing recognition of type 2 diabetes and genetic forms of diabetes in the paediatric population has important treatment implications. ...New insights into the pathogenesis of diabet
Although most children with diabetes have type 1 diabetes, the increasing recognition of type 2 diabetes and genetic fo …
5,865 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback